Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
26.11.24 | MEDICURE INC - 6-K, Report of foreign issuer | - | SEC Filings | ||
26.11.24 | Medicure, Inc.: Medicure Reports Financial Results For Quarter Ended September 30, 2024 | 332 | ACCESS Newswire | WINNIPEG, MB / ACCESSWIRE / November 25, 2024 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals... ► Artikel lesen | |
26.11.24 | Medicure GAAP EPS of C$0.07, revenue of C$5.2M | 5 | Seeking Alpha | ||
19.11.24 | Medicure Inc (2): Medicure to release Q3 2024 results Nov. 15 | 2 | Stockwatch | ||
18.11.24 | Medicure, Inc.: Medicure to Present Financial Results on November 26, 2024 Call at 8:30 AM ET for Quarter Ended September 30, 2024 and Announces Resignation of Board Member | 283 | ACCESS Newswire | WINNIPEG, MB / ACCESSWIRE / November 18, 2024 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals... ► Artikel lesen | |
18.11.24 | MEDICURE INC - 6-K, Report of foreign issuer | 4 | SEC Filings | ||
MEDICURE Aktie jetzt für 0€ handeln | |||||
25.10.24 | Medicure Inc (2): Medicure receives 1.5M euros as dispute settlement | 1 | Stockwatch | ||
25.10.24 | Medicure, Inc.: Medicure Announces Positive Settlement of Product Development and Supply Contracts | 507 | ACCESS Newswire | WINNIPEG, MB / ACCESSWIRE / October 24, 2024 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and... ► Artikel lesen | |
26.08.24 | MEDICURE INC - 6-K, Report of foreign issuer | - | SEC Filings | ||
14.08.24 | Medicure, Inc.: Medicure Announces Closing of Asset Purchase Agreement with Canam Bioresearch for Acquisition of Intellectual Property | 776 | ACCESS Newswire | WINNIPEG, MB / ACCESSWIRE / August 14, 2024 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and... ► Artikel lesen | |
14.08.24 | Medicure, Inc.: Medicure Reports Financial Results for Quarter Ended June 30, 2024 | 295 | ACCESS Newswire | WINNIPEG, ON / ACCESSWIRE / August 14, 2024 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and... ► Artikel lesen | |
24.06.24 | Medicure, Inc.: Medicure Announces Signing of Asset Purchase Agreement with CanAm Bioresearch Inc. for Acquisition of Intellectual Property | 389 | ACCESS Newswire | WINNIPEG, MB / ACCESSWIRE / June 24, 2024 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and... ► Artikel lesen | |
28.05.24 | Medicure, Inc.: Medicure Reports Financial Results for Quarter Ended March 31, 2024 and Annual General Meeting Director Election Results | 714 | ACCESS Newswire | WINNIPEG, MB / ACCESSWIRE / May 28, 2024 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare... ► Artikel lesen | |
23.04.24 | Medicure, Inc.: Medicure Receives US FDA Fast Track Designation for MC-1 for PNPO Deficiency | 626 | ACCESS Newswire | WINNIPEG, MB / ACCESSWIRE / April 23, 2024 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and... ► Artikel lesen | |
08.04.24 | Medicure, Inc.: Medicure Reports Financial Results for Quarter and Year Ended December 31, 2023 | 436 | ACCESS Newswire | WINNIPEG, MB / ACCESSWIRE / April 8, 2024 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTCPINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare... ► Artikel lesen | |
05.04.24 | Medicure, Inc.: Medicure To Present Financial Results on April 9, 2024 Call at 8:30 AM ET for Quarter and Year Ended December 31, 2023 | 730 | ACCESS Newswire | WINNIPEG, MB / ACCESSWIRE / April 4, 2024 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
NOVO NORDISK | 74,58 | +0,05 % | Novo Nordisk: Doppelte Kaufempfehlung | Die Aktie von Novo Nordisk kämpft derzeit weiter mit der 38-Tage-Linie. Hatte das Papier in der vergangenen Woche erneut Schwung aufbauen können, ist dieser in der neuen Woche bereits wieder abgeebbt.... ► Artikel lesen | |
PFIZER | 24,315 | -0,06 % | U.S. FDA Approves Pfizer's ADCETRIS Combo For Relapsed Or Refractory Large B Cell Lymphoma | NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) Wednesday announced the FDA approval of its supplemental Biologics License Application or sBLA for ADCETRIS otherwise known as brentuximab vedotin... ► Artikel lesen | |
GILEAD SCIENCES | 99,32 | +0,13 % | Dividende steigt: Gilead Sciences übertrifft Erwartungen: Aktie steigt nach starkem Q4-Ergebnis | © Foto: Pavlo Gonchar - picture alliance / ZUMAPRESS.comGilead Sciences schlägt mit seinen Quartalszahlen die Erwartungen der Wall Street und bleibt auch für 2025 bullish. Vor allem die Nachfrage nach... ► Artikel lesen | |
AURORA CANNABIS | 6,030 | +0,17 % | Da ist Druck im Kessel: Canopy Growth taumelt. Aurora Cannabis mit Paukenschlag. Was macht Tilray? | © Foto: adobe.stock.comDie Quartalsberichtssaison hat den Cannabis-Sektor endgültig erreicht. Dass es einmal mehr keine einfache Berichtssaison werden würde, war zu erwarten. Immerhin gab es aber den... ► Artikel lesen | |
GSK | 17,295 | -0,72 % | DEUTSCHE BANK RESEARCH stuft GSK auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für GSK nach Zahlen und einem Treffen mit dem Management auf "Hold" mit einem Kursziel von 1450 Pence belassen. Es habe eine... ► Artikel lesen | |
ABBVIE | 184,42 | +0,34 % | AbbVie Elects CEO Robert Michael To Additional Position Of Chairman | WASHINGTON (dpa-AFX) - Biopharmaceutical company AbbVie, Inc. (ABBV) announced Friday that its board of directors has unanimously elected chief executive officer Robert Michael to assume the... ► Artikel lesen | |
CANOPY GROWTH | 1,802 | +0,22 % | Canopy Growth Corporation Expands Deep Space Propulsion Beverage Lineup | ||
ELI LILLY | 803,50 | -0,15 % | Neue Hoffnung für Millionen?: Eine US-Biotech-Firma sorgt für Furore - steckt hier die Zukunft der Krebsheilung? | ||
TILRAY BRANDS | 0,893 | +0,50 % | Tilray shifts large-scale production away from Revolver Brewing facility | ||
BRISTOL-MYERS SQUIBB | 51,20 | -0,35 % | Bristol Myers Squibb Cancer Immunotherapy Flunks a Key Test in Melanoma | ||
TEVA | 15,450 | -0,32 % | Medincell: Completion of the Pivotal Phase 3 Trial for Olanzapine LAI in Schizophrenia Conducted by Teva Pharmaceuticals | Medincell to receive a $5 million development milestone payment from Teva with SOLARIS study completion (last patient last visit) Richard Malamut, Chief Medical Officer at Medincell comments:... ► Artikel lesen | |
VERTEX PHARMACEUTICALS | 437,55 | +0,01 % | Vertex mit Zahlen - 2025 "wichtiges Jahr" | Das US-Biotech-Unternehmen Vertex Pharmaceuticals hat am Montag nach US-Börsenschluss seine Zahlen für das vierte Quartal vorgelegt. Beim Umsatz konnte Vertex die Prognosen übertreffen, beim Gewinn... ► Artikel lesen | |
ABBOTT LABORATORIES | 124,86 | +0,34 % | Abbott: How Myths About Diabetes Have a Real Impact on Health | Abbott NORTHAMPTON, MA / ACCESS Newswire / February 10, 2025 / Four out of 10 people living with diabetes miss appointments due to shame1. How can we change that?A lot of things we commonly hear about... ► Artikel lesen | |
TAAT GLOBAL ALTERNATIVES | 0,160 | +4,23 % | TAAT Global Alternatives, Inc. unterzeichnet eine unverbindliche Absichtserklärung zur Übernahme von Premium Products LLC, um sein alternatives Produktportfolio zu erweitern | Vancouver, BC, 17. Januar 2025 / IRW-Press / TAAT Global Alternatives, Inc. (CSE: TAAT) (OTCQX: TOBAF) (FWB: 2TP) (das "Unternehmen" oder "TAAT") freut sich, die
Unterzeichnung einer unverbindlichen... ► Artikel lesen | |
MPH HEALTH CARE | 23,000 | +0,88 % | MPH Health Care Aktie: Hauptversammlung im Überblick | Die MPH Health Care AG verzeichnete am 7. Februar 2025 einen leichten Kursrückgang von 1,72 Prozent auf 22,80 EUR. Der Gesundheitsinvestor, der sich auf Beteiligungen im Pharma- und Medizintechniksektor... ► Artikel lesen |